The American Society of Clinical Oncology (ASCO) invites you to help shape a new initiative to foster participation in cancer treatment trials to more fully reflect the diversity of people at risk for or living with cancer. As part of the ASCO and the Association of the Community Cancer Centers (ACCC) recently announced collaboration, ASCO is seeking novel strategies and practical solutions to increase participation of under-represented racial and ethnic populations in cancer treatment trials. The ASCO-ACCC Request for Ideas closes August 24, and submissions are being accepted online.
The lack of racial and ethnic diversity in clinical trials continues to be a persistent problem in cancer research—one that directly impacts cancer care. Only 4% to 6% of trial participants are Black and 3% to 6% are Hispanic, whereas they represent 15% and 13% of all patients with cancer, respectively. If clinical trials don’t represent the individuals being treated, the state of science suffers and patients with life-threatening conditions may miss out on the best—perhaps only—treatment option for their condition
One intervention method will not work for every community, but with input from oncologists across the country, ASCO and ACCC aim to develop a toolkit for oncologists to address the specific barriers they’re facing with recruitment and retention of underrepresented populations. Help remove barriers by submitting an idea today.
ASCO President Lori J. Pierce, MD, FASTRO, FASCO, and ACCC President Randall A. Oyer, MD, have found the collaboration of the two organizations to come naturally, and are both dedicated to finding multi-faceted approaches to implement the strategies submitted. The ASCO-ACCC Steering Group will review and select ideas that may be modified, combined, implemented, and evaluated by ASCO and ACCC.